About
Rafael Bottos is a biotech entrepreneur and the co-founder and CEO of Aptah Bio, a San Carlos-based company developing its RNA WiCo platform and lead compound APT20TTMG. He is also listed as a co-founder and board member of Vesper Bio, and earlier portfolio material from Antera identifies him as CEO of Welle Laser. In the longevity ecosystem, he appears primarily as an operator building and fundraising for biotech companies rather than as an investor or fund manager.
Areas of interest
longevitybiotechaging biologyRNA therapeuticscancer